Quanhecheng is committed to becoming the most trusted partner of life science enterprises, always adhering to innovation leadership, actively promoting the deep integration of government, industry, academia, and research, expanding the boundaries of technology and products, and forming a highly relevant integrated business model. With years of technological accumulation, Quanhecheng's major technology platforms are at the forefront of the industry in their respective fields. They have successively built synthesis technology universal platforms, cross technology application platforms, gene therapy delivery platforms, nucleic acid drug discovery platforms, IVD technology service platforms, and intellectual property operation platforms. At the same time, Quanhecheng will achieve dual promotion of new technology industrialization and source technology innovation and breakthroughs in the discovery, research and development verification, testing platform, core raw material production, analysis and quality control of nucleic acid drug lead compounds, and ultimately become a leading domestic and world-class biotechnology service-oriented raw material supplier.